INTRODUCTION {#sec1-1}
============

Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is an acute, severe, unpredictable cutaneous reaction to drugs leading to skin eruptions and visceral involvement. The characteristic features include a diffuse maculopapular rash, facial edema, exfoliative dermatitis, fever, lymphadenopathy, visceral involvement (renal impairment, carditis, pneumonitis), hematological abnormalities (mainly eosinophilia, lymphocytosis and atypical lymphocytes).\[[@ref1]\] DRESS was first described by Chaiken *et al*. in 1950 with dilantin (phenytoin).\[[@ref2]\] It occurs with numerous drugs (e.g., anticonvulsants, sulphonamides, and allopurinol).\[[@ref3]\] DRESS with beta-lactam antibiotics has been also reported. Ceftriaxone, a cephalosporin is used for variety of infections. This drug is known to be associated with rare and mild side-effects such as urticaria, skin rash, diarrhea, vomiting, transient neutropenia, and hemolysis. However, ceftriaxone-induced DRESS is rare. To the best of our knowledge, there have been only two cases reported in the literature.\[[@ref4]\] We report herein one case of DRESS induced by ceftriaxone.

CASE REPORT {#sec1-2}
===========

A 33-year-old male was admitted (10, November 2013) with fever and dry cough of 4 days duration in a peripheral hospital. The patient had no known comorbidities and didn\'t give history of any drug allergy in the past. On examination, he was found to be febrile (100 F), had a pulse of 90/min, blood pressure of 126/80 mmHg, respiratory rate of 24/min and had crackles in right infrascapular region. Based on the clinical examination and chest X-ray, he was diagnosed to have pneumonia. His hematological and biochemical parameters were within the normal limit. He was started on injection of ceftriaxone (1 g, intravenous, every 24 h). On the 3^rd^ day of admission, his fever dropped down and he was afebrile by day 6. Ceftriaxone was continued. On the 7^th^ day, he developed transaminases elevation, alanine aminotransferase (alanine transaminase (ALT) =219 IU/L; aspartate aminotransferase (AST) =356 IU/L; alkaline phosphatase (ALP) =246 IU/L). On the 11^th^ day, he had recurrence of high grade fever with maculopapular rash over trunk, extremities and swelling of wrist and ankles \[Figures [1](#F1){ref-type="fig"}--[3](#F3){ref-type="fig"}\]. He was transferred to our center on day 11, with the following laboratory findings: Hemoglobin = 11.4 g%; total leucocyte count (TLC) =1900/cm^3^ with relative eosinophilia of 10%; platelets (Plt) count = 1,47,000/cm^3^(previous Plt = 2,00,000/cm^3^). His peripheral blood smear showed leucopenia with relative eosinophilia, 6% atypical lymphocytes, Plt: 1,50,000/cm^3^ and no evidence of hemolysis and hemoparasite. His liver enzymes were markedly raised as below: ALT = 766 IU/L; AST = 2424 IU/L; ALP = 162 IU/L, and lactate dehydrogenase = 3732 IU/L. His urea and creatinine were 46 and 1.7 mg/dL, respectively. Bone marrow aspiration/biopsy was done and presented to be normal. His hepatitis B surface antigen, antihepatitis C virus antibody, and human immunodeficiency virus antibody were all negative. Rapid diagnostic test for malaria and dengue serology were negative. A diagnosis of ceftriaxone-induced DRESS was made, based upon European Registry of severe cutaneous adverse reactions (RegiSCAR) criteria.\[[@ref5]\] Ceftriaxone was stopped and patient was treated with injection of dexamethasone 4 mg, thrice a day for initial 2 days and later oral prednisolone 60 mg/day, which was gradually tapered over 6 weeks. Only after 48 h of steroid therapy, patient started improving symptomatically and became afebrile after 72 h. His rash cleared over 5 days and his hematological and biochemical parameters started improving after 72 h and became normal by day 8 of starting steroids \[[Table 1](#T1){ref-type="table"}\].
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Hematological and biochemical laboratory findings of the patient
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DISCUSSION {#sec1-3}
==========

Drug rash with eosinophilia and systemic symptoms syndrome is a life-threatening adverse reaction to a drug with associated mortality rate of about 10%. Proposed mechanism of pathogenesis of DRESS has been failure of drug detoxification pathways leading to accumulation of harmful metabolites which in turn activate CD4 + CD8 + T-cells. These cells release interleukin-5 which activates eosinophils and sets up an inflammatory cascade.\[[@ref6]\] Earlier, there was no consistent name for this syndrome and it was named after the culprit drug as phenytoin syndrome, allopurinol hypersensitivity syndrome, dapsone syndrome, etc., Bocquet *et al*.\[[@ref7]\] proposed the term drug rash with eosinophilia and systemic symptoms (DRESS) to simplify the nomenclature of drug-hypersensitivity syndromes. Since then, various criteria have been evolved to define DRESS \[[Table 2](#T2){ref-type="table"}\]. Among all the criteria being used to diagnose DRESS, RegiSCAR criteria\[[@ref5]\] is the most widely used.
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Scoring systems for diagnosis of DRESS
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Our patient was diagnosed as DRESS syndrome as he was fulfilling all Bocquet *et al*.\[[@ref7]\] proposed criteria and criteria 1, 2, 3, 4, 6, 7 of RegiSCAR.\[[@ref5]\] However, except for fever, no other Japanese consensus group criteria\[[@ref8]\] was being fulfilled, as the symptoms and signs had appeared early (11 days of ceftriaxone administration), there was leucopenia (TLC = 1900) rather than leukocytosis, and absolute eosinophil count was only 190/cm^3^ though there was relative increase in eosinophils (10% of TLC). Patient was treated as having ceftriaxone induced DRESS syndrome and he showed a uneventful recovery with steroids and cessation of the offending drug.

The culprit drugs most commonly associated with DRESS are anticonvulsants, allopurinol, minocycline, sulfasalazine, dapsone, nevirapine, and abacavir.\[[@ref3]\] Ceftriaxone-induced DRESS is rare . To our knowledge, there have been only two cases of ceftriaxone-induced DRESS reported in the literature.\[[@ref4]\] Until date, ceftriaxone has not been included in the list of drugs causing DRESS. DRESS is generally treated with moderate-or high-dose corticosteroids, but response may be suboptimal and prolonged treatment with systemic glucocorticoid may be required. Other immunosuppressive agents, such as cyclosporine, have also been used.\[[@ref9]\]
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